Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
43.34
-3.85 (-8.16%)
At close: Feb 5, 2026, 4:00 PM EST
46.12
+2.78 (6.41%)
Pre-market: Feb 6, 2026, 7:52 AM EST
Novo Nordisk Employees
As of December 31, 2025, Novo Nordisk had 69,505 total employees, including 76,302 full-time and 1,047 part-time employees. The number of employees decreased by 7,844 or -10.14% compared to the previous year.
Employees
69,505
Change (1Y)
-7,844
Growth (1Y)
-10.14%
Revenue / Employee
$699,061
Profits / Employee
$231,692
Market Cap
196.91B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 69,505 | -7,844 | -10.14% |
| Dec 31, 2024 | 77,349 | 13,030 | 20.26% |
| Dec 31, 2023 | 64,319 | 9,134 | 16.55% |
| Dec 31, 2022 | 55,185 | 6,707 | 13.84% |
| Dec 31, 2021 | 48,478 | 3,155 | 6.96% |
| Dec 31, 2020 | 45,323 | 2,065 | 4.77% |
| Dec 31, 2019 | 43,258 | 56 | 0.13% |
| Dec 31, 2018 | 43,202 | 520 | 1.22% |
| Dec 31, 2017 | 42,682 | 711 | 1.69% |
| Dec 31, 2016 | 41,971 | 1,333 | 3.28% |
| Dec 31, 2015 | 40,638 | -319 | -0.78% |
| Dec 31, 2014 | 40,957 | 2,521 | 6.56% |
| Dec 31, 2013 | 38,436 | 3,705 | 10.67% |
| Dec 31, 2012 | 34,731 | 2,099 | 6.43% |
| Dec 31, 2011 | 32,632 | 2,149 | 7.05% |
| Dec 31, 2010 | 30,483 | 1,154 | 3.93% |
| Dec 31, 2009 | 29,329 | 2,754 | 10.36% |
| Dec 31, 2008 | 26,575 | 1,059 | 4.15% |
| Dec 31, 2007 | 25,516 | 1,903 | 8.06% |
| Dec 31, 2006 | 23,613 | 1,153 | 5.13% |
| Dec 31, 2005 | 22,460 | 1,735 | 8.37% |
| Dec 31, 2004 | 20,725 | 1,969 | 10.50% |
| Dec 31, 2003 | 18,756 | 751 | 4.17% |
| Dec 31, 2002 | 18,005 | 1,864 | 11.55% |
| Dec 31, 2001 | 16,141 | 2,389 | 17.37% |
| Dec 31, 2000 | 13,752 | 1,758 | 14.66% |
| Dec 31, 1999 | 11,994 | 345 | 2.96% |
| Dec 31, 1998 | 11,649 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,100 |
| AstraZeneca | 92,900 |
| Sanofi | 82,878 |
| Pfizer | 81,000 |
| Novartis AG | 75,267 |
| Merck & Co. | 75,000 |
| GSK plc | 68,629 |
| AbbVie | 55,000 |
NVO News
- 50 minutes ago - Novo Stock Rises, Hims & Hers Tanks. This Could Shift the Weight-Loss Copycat Battle. - Barrons
- 2 hours ago - Why Novo Nordisk stock fell 7% after a telehealth startup's announcement - Fast Company
- 3 hours ago - Novo Nordisk stock climbs out of hole on FDA chief's threat to block Hims and Hers pill - Market Watch
- 4 hours ago - Novo Nordisk shares rebound as FDA targets illegal drug copies - Reuters
- 9 hours ago - Novo Nordisk A/S (NOVO:CA) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 12 hours ago - PharmaZee GLP-1 Prescription Information Updated as Novo Nordisk Raises Compounding Concerns and Consumer Interest in Telehealth Semaglutide Access Grows in 2026 - GlobeNewsWire
- 17 hours ago - Why a $49 weight-loss pill is rattling Novo Nordisk and Eli Lilly - Invezz
- 18 hours ago - Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons - GlobeNewsWire